NIBSC20/112 IVIG + Anti-D (13/148) x2 Negative Control IVIG (12/300) x2

NIBSC20/112  IVIG + Anti-D (13/148) x2 Negative Control IVIG (12/300) x2

产品详情如下,更多产品详情,请咨询客服,供实验室使用!

Product description IVIG + Anti-D (13/148) x2 Negative Control IVIG (12/300) x2
Product number 20/112 NIBSC20/112
Category Biotherapeutics Immunoglobulins and Immune SeraBiotherapeutics
Keywords haemagglutination, hemagglutination, IGIV, pharmacopoeial specification, direct method, RhD
Type of standard Non WHO Reference Material
Customer notes Replaces panel 05/242
Instructions for Use 20-112.pdf Instructions for Use
Minimum quantity 1

部分相关产品如下,更多相关产品的详细信息,请咨询客服,供实验室使用!

Related Products

NDS Anti-Newcastle Disease Serum. WHO International Standard         抗新城疫血清。世界卫生组织国际标准

16/352     Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)   抗亚系寨卡病毒抗体(人)(第一个国际标准)

78/545     Anti-Aspergillus fumigatus Serum, Human      抗烟曲霉血清,人

07/164     Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)       抗乙型肝炎表面抗原(抗-HBs)免疫球蛋白(第二国际标准)

00/556     Influenza anti-B/Johannesburg/5/99/ Serum         抗乙型流感/约翰内斯堡/99/血清